WinstonEdwardBarzellMD

PubMed

• 67 citations
  A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in pa...
  Yipeng Hu, Hashim U. Ahmed, Timothy J. Carter, Nimalan Arumainayagam, Emilie Lecornet, Winston E. Barzell, Alex Freeman, Pierre Nevoux, David J. Hawkes, Arnauld Viller...> ;BJU International. 2012 Sep 1
• 71 citations
  Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer
  Winston E. Barzell, Myron R. Melamed, Paul Cathcart, Caroline M. Moore, Hashim U. Ahmed, Mark Emberton> ;The Journal of Urology. 2012 Sep 1
• 107 citations
  Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy.
  Gary Onik, Winston E. Barzell> ;Urologic Oncology. 2008 Sep 1
• 136 citations
  Appropriate Patient Selection in the Focal Treatment of Prostate Cancer: The Role of Transperineal 3-Dimensional Pathologic Mapping of the Prostate—A 4-Year Experience
  Winston E. Barzell, Myron R. Melamed> ;Urology. 2007 Dec 1
• 57 citations
  Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.
  David G. Bostwick, David J. Waters, Edward R. Farley, Isabelle Meiers, Daniel B. Rukstalis, William A. Cavanaugh, Haakon Ragde, Martin Dineen, Duke Bahn, Stephen Scion...> ;Urology. 2007 Dec 1
• 1 citations
  Prevention of prostate cancer with finasteride.
  Winston E Barzell> ;The New England Journal of Medicine. 2003 Oct 16
• 89 citations
  Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial
  Claus G. Roehrborn, Glenn M. Preminger, Phil Newhall, John D. Denstedt, Hassan Razvi, L.Joseph Chin, Aaron Perlmutter, Winston E. Barzell, Willet F. Whitmore, Ralph J....> ;Urology. 1998 Jan 1
• 30 citations
  Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor
  Davor Vugrin, Willet F. Whitmore, Esteban Cvitkovic, Harry Grabstald, Pramod C. Sogani, Winston E. Barzell, Robert B. Golbey> ;Cancer. 1981 Mar 1
• 75 citations
  A critical analysis of response criteria in patients with prostatic cancer treated with CIS‐diamminedichloride platinum II
  Alan Yagoda, Robin C. Watson, Ronald B. Natale, Winston E. Barzell, Pramod C. Sogani, Harry Grabstald, Willet F. Whitmore> ;Cancer. 1979 Nov 1
• 87 citations
  Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer.
  Jackson E. Fowler, Winston E. Barzell, Willet F. Whitmore> ;The Journal of Urology. 1979 Apr 1
• 48 citations
  Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer.
  Alan Yagoda, Nancy E. Kemeny, Robin C. Watson, Winston E. Barzell, Harry Grabstald, Willet F. Whitmore> ;Cancer. 1978 Jun 1
• 3 citations
  Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer.
  Winston E. Barzell, Willet F. Whitmore> ;Urological Research. 1978 Jan 1
• 150 citations
  Prostatic Adenocarcinoma: Relationship of Grade and Local Extent to the Pattern of Metastases
  Winston E. Barzell, Michael A. Bean, Willet F. Whitmore> ;The Journal of Urology. 1977 Aug 1
• 90 citations
  Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection.
  Willet F. Whitmore, Mostafa Batata, Winston E. Barzell> ;International Journal of Radiation Oncology, Biology, Physics. 1977 Jul 1
• 25 citations
  Adriamycin and cyclophosphamide in advanced bladder cancer.
  Alan Yagoda, Robin C. Watson, Grabstald H, Winston E. Barzell, Willet F. Whitmore> ;Cancer Treatment Reports. 1977 Jan 1
• 9 citations
  Metabolism of rat alpha1-fetoprotein.
  Brian Colquhoun, Phil Gold, Winston Barzell, David D. Oakes, Joseph Shuster> ;Cancer Research. 1974 Sep 1
• A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.
  Trachtenberg, J., Gittleman, M., Steidle, C., Barzell, W., Friedel, W., Pessis, D., Fotheringham, N., Campion, M., Garnick, M. B.> ;J Urol. 2002 Apr
• Clinical significance of biologic markers: Memorial Hospital experience.
  Barzell, W. E., Whitmore, W. F.> ;Semin Oncol. 1979 Mar
• Editorial comment.
  Kaplon, D. M., Barzell, W.> ;Urology. 2010 May
• Join now to see all